Viewing Study NCT06225427

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT06225427
Status: RECRUITING
Last Update Posted: 2025-10-17
First Post: 2024-01-13
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Gilteritinib for the Treatment of ALK NSCLC
Sponsor: University of Michigan Rogel Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Non-Small Cell Carcinoma View
None Stage IV Lung Cancer AJCC v8 View
Keywords: